Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Kyowa Hakko Kirin Pharma, Inc.
Sponsor:
Collaborator:
Teva Pharma
Information provided by (Responsible Party):
Kyowa Hakko Kirin Pharma, Inc.
ClinicalTrials.gov Identifier:
NCT01447732
First received: September 30, 2011
Last updated: January 22, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)